Justin P. Kline to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Justin P. Kline has written about Drug Resistance, Neoplasm.
Connection Strength
0.106
-
Phase II study of immunomodulation with granulocyte-macrophage colony-stimulating factor, interleukin-2, and rituximab following autologous stem cell transplant in patients with relapsed or refractory lymphomas. Leuk Lymphoma. 2010 Jul; 51(7):1241-50.
Score: 0.072
-
Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy. J Immunother Cancer. 2019 07 10; 7(1):175.
Score: 0.034